BRIEF-LifeMD Files Non-Timely 10-Q With US SEC

Reuters

Nov 13, 2025

Nov 12 (Reuters) - LifeMD Inc LFMD.O:

LIFEMD INC FILES NON-TIMELY 10-Q WITH U.S. SEC
LIFEMD - IDENTIFIES ABOUT $4.6 MILLION IN CUMULATIVE OVER RECOGNITION OF REVENUE, WITH OFFSETTING AMOUNTS IN RELATED BALANCE SHEET ACCOUNTS
LIFEMD INC - EVALUATING POTENTIAL IMPACT ON INTERNAL CONTROL OVER FINANCIAL REPORTING

Source text: [ID:n0001493152-25-022009]

Further company coverage: LFMD.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2583558995"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2583558995\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2583558995?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-13 06:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2583558995","market":"us","top_or_hot":-1,"title":"BRIEF-LifeMD Files Non-Timely 10-Q With US SEC","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-LifeMD Files Non-Timely 10-Q With US SEC</title></head><body><p><span>Nov 12 (Reuters)</span><span> - </span>LifeMD Inc <span>LFMD.O</span>:</p><ul><li><p>LIFEMD INC FILES NON-TIMELY 10-Q WITH U.S. SEC</p></li><li><p>LIFEMD - IDENTIFIES ABOUT $4.6 MILLION IN CUMULATIVE OVER RECOGNITION OF REVENUE, WITH OFFSETTING AMOUNTS IN RELATED BALANCE SHEET ACCOUNTS</p></li><li><p>LIFEMD INC - EVALUATING POTENTIAL IMPACT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</p></li></ul><p>Source text: [ID:n0001493152-25-022009]</p><p>Further company coverage: <span>LFMD.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-LifeMD Files Non-Timely 10-Q With US SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-LifeMD Files Non-Timely 10-Q With US SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-11-13 06:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-LifeMD Files Non-Timely 10-Q With US SEC</title></head><body><p><span>Nov 12 (Reuters)</span><span> - </span>LifeMD Inc <span>LFMD.O</span>:</p><ul><li><p>LIFEMD INC FILES NON-TIMELY 10-Q WITH U.S. SEC</p></li><li><p>LIFEMD - IDENTIFIES ABOUT $4.6 MILLION IN CUMULATIVE OVER RECOGNITION OF REVENUE, WITH OFFSETTING AMOUNTS IN RELATED BALANCE SHEET ACCOUNTS</p></li><li><p>LIFEMD INC - EVALUATING POTENTIAL IMPACT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</p></li></ul><p>Source text: [ID:n0001493152-25-022009]</p><p>Further company coverage: <span>LFMD.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nFWN3WO1FW:1","article_id":"2583558995","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2583558995","pubTimestamp":1762986136,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-LifeMD Files Non-Timely 10-Q With US SECNov 12  - LifeMD Inc LFMD.O:LIFEMD INC FILES NON-TIMELY 10-Q WITH U.S. SECLIFEMD - IDENTIFIES ABOUT $4.6 MILLION IN CUMULATIVE OVER RECOGNITION OF REVENUE, WITH OFFSETTING AMOUNTS IN RELATED BALANCE SHEET ACCOUNTSLIFEMD INC - EVALUATING POTENTIAL IMPACT ON INTERNAL CONTROL OVER FINANCIAL REPORTINGSource text: [ID:n0001493152-25-022009]Further company coverage: LFMD.O ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","BK4183":"个人用品","LFMD":"LifeMD Inc."},"translate_title":"BRIEF-LifeMD向美国SEC提交不及时的10-Q报告","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LFMD":0.9},"content_text":"BRIEF-LifeMD Files Non-Timely 10-Q With US SECNov 12 (Reuters) - LifeMD Inc LFMD.O:LIFEMD INC FILES NON-TIMELY 10-Q WITH U.S. SECLIFEMD - IDENTIFIES ABOUT $4.6 MILLION IN CUMULATIVE OVER RECOGNITION OF REVENUE, WITH OFFSETTING AMOUNTS IN RELATED BALANCE SHEET ACCOUNTSLIFEMD INC - EVALUATING POTENTIAL IMPACT ON INTERNAL CONTROL OVER FINANCIAL REPORTINGSource text: [ID:n0001493152-25-022009]Further company coverage: LFMD.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}